CD14 and IL6 polymorphisms are associated with a pro-atherogenic profile in young adults with acute myocardial infarction

Journal of Thrombosis and Thrombolysis

Volumn 36, Issue 3, 2013, Pages 332-340

  Lima Neto, Lidio Gonçalves ^a   Hirata, Rosario Dominguez Crespo ^a   Luchessi, André Ducati ^a   Silbiger, Vivian Nogueira ^a   Stephano, Marco Antonio ^a   Sampaio, Marcelo Ferraz ^b   Armaganijan, Dikran ^b   Hirata, Mario Hiroyuki ^a  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

^b INSTITUTO DANTE PAZZANESE DE CARDIOLOGIA   (Brazil)

Author keywords

CD14; Gene polymorphism; IL 6; Myocardial infarction; TLR4

Indexed keywords

APOLIPOPROTEIN A1; CD14 ANTIGEN; GENOMIC DNA; GLUCOSE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; INTERLEUKIN 6; NITRATE; TOLL LIKE RECEPTOR 4; TRIACYLGLYCEROL; VERY LOW DENSITY LIPOPROTEIN CHOLESTEROL;

ACUTE HEART INFARCTION; ADULT; ARTICLE; ATHEROGENESIS; ATHEROSCLEROSIS; BLOOD VESSEL PARAMETERS; CD14 GENE; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; ENDOTHELIAL DYSFUNCTION; FEMALE; FLOW MEDIATED BY NITRATE; FLOW MEDIATED VASODILATATION; GENETIC ANALYSIS; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GENETIC VARIABILITY; GENOTYPE; GLUCOSE BLOOD LEVEL; HUMAN; HYPERGLYCEMIA; HYPERTRIGLYCERIDEMIA; IL6 GENE; INFLAMMATION; LIPID BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; NUCLEOTIDE SEQUENCE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; TLR4 GENE; TRIACYLGLYCEROL BLOOD LEVEL;

ADULT; AGED; ANTIGENS, CD14; ATHEROSCLEROSIS; FEMALE; GENOTYPE; HUMANS; INTERLEUKIN-6; LIPIDS; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; POLYMORPHISM, GENETIC; TOLL-LIKE RECEPTOR 4;

EID: 84884812661     PISSN: 09295305     EISSN: 1573742X     Source Type: Journal    
DOI: 10.1007/s11239-012-0841-4     Document Type: Article

References (54)

1. Corrado E et al (2010) An update on the role of markers of inflammation in atherosclerosis. J Atheroscler Thromb 17(1):1-11
2. Tousoulis D et al (2012) The role of nitric oxide on endothelial function. Curr Vasc Pharmacol 10(1):4-18
3. Lee S et al (2011) Effects of interventions on oxidative stress and inflammation of cardiovascular diseases. World J Cardiol 3(1):18-24
4. Tan J et al (2009) Prognostic value of interleukin-6 during a 3-year follow-up in patients with acute ST-segment elevation myocardial infarction. Heart Vessels 24(5):329-334
5. Mann DL et al (2010) Innate immunity in the adult mammalian heart: for whom the cell tolls. Trans Am Clin Climatol Assoc 121:34-50
6. Hodgkinson CP, Ye S (2011) Toll-like receptors, their ligands, and atherosclerosis. ScientificWorldJournal 11:437-453
7. Peri F et al (2010) Exploring the LPS/TLR4 signal pathway with small molecules. Biochem Soc Trans 38(5):1390-1395
8. Olivieri F et al (2006) Genetic polymorphisms of inflammatory cytokines and myocardial infarction in the elderly. Mech Ageing Dev 127(6):552-559
9. Brull DJ et al (2001) Interleukin-6 gene -174g>c and -572g>c promoter polymorphisms are strong predictors of plasma interleukin-6 levels after coronary artery bypass surgery. Arterioscler Thromb Vasc Biol 21(9):1458-1463
10. Sanderson SC et al (2009) Association between IL6 gene variants -174G>C and -572G>C and serum IL-6 levels: Interactions with social position in the Whitehall II cohort. Atherosclerosis 204(2):459-464
11. Manginas A et al (2008) Inflammatory cytokine gene variants in coronary artery disease patients in Greece. Coron Artery Dis 19(8):575-582
12. Vakili H et al (2011) Genetic polymorphism of interleukin-6 gene and susceptibility to acute myocardial infarction. Coron Artery Dis 22(5):299-305
13. Koenig W et al (2002) CD14 C(-260)->T polymorphism, plasma levels of the soluble endotoxin receptor CD14, their association with chronic infections and risk of stable coronary artery disease. J Am Coll Cardiol 40(1):34-42
14. Rizzello V et al (2010) Role of the CD14 C(-260)T promoter polymorphism in determining the first clinical manifestation of coronary artery disease. J Cardiovasc Med (Hagerstown) 11(1):20-25
15. Hermann M et al (2012) CRP and CD14 polymorphisms correlate with coronary plaque volume in patients with coronary artery disease-IVUS substudy of the ENCORE trials. Atherosclerosis 220(1):172-176
16. Shimada K et al (2000) Common polymorphism in the promoter of the CD14 monocyte receptor gene is associated with acute myocardial infarction in Japanese men. Am J Cardiol 86(6):682-684 A8
17. Balistreri CR et al (2009) TLR4 polymorphisms and ageing: Implications for the pathophysiology of age-related diseases. J Clin Immunol 29(4):406-415
18. Smirnova I et al (2000) Phylogenetic variation and polymorphism at the toll-like receptor 4 locus (TLR4). Genome Biol 1(1):RESEARCH002.1-RESEARCH002.10
19. Kiechl S et al (2002) Toll-like receptor 4 polymorphisms and atherogenesis. N Engl J Med 347(3):185-192
20. Boekholdt SM et al (2003) Variants of toll-like receptor 4 modify the efficacy of statin therapy and the risk of cardiovascular events. Circulation 107(19):2416-2421
21. Ameziane N et al (2003) Association of the Toll-like receptor 4 gene Asp299Gly polymorphism with acute coronary events. Arterioscler Thromb Vasc Biol 23(12):e61-e64
22. Balistreri CR et al (2004) Role of Toll-like receptor 4 in acute myocardial infarction and longevity. JAMA 292(19):2339-2340
23. Fukushima R et al (2009) Expression levels of Toll-like receptor genes in coronary atherosclerotic lesions of patients with acute coronary syndrome or stable angina pectoris. Circ J 73(8):1479-1484
24. Kablak-Ziembicka A et al (2011) Relationship between carotid intima-media thickness, cytokines, atherosclerosis extent and a two-year cardiovascular risk in patients with arteriosclerosis. Kardiol Pol 69(10):1024-1031
25. Lopez-Mejias R et al (2011) Lack of association between IL6 single nucleotide polymorphisms and cardiovascular disease in Spanish patients with rheumatoid arthritis. Atherosclerosis 219(2):655-658
26. Edfeldt K et al (2004) Association of hypo-responsive toll-like receptor 4 variants with risk of myocardial infarction. Eur Heart J 25(16):1447-1453
27. Mendis S et al (2011) World Health Organization definition of myocardial infarction: 2008-09 revision. Int J Epidemiol 40(1):139-146
28. Obesity: Preventing and managing the global epidemic. Report of a WHO consultation. World Health Organ Tech Rep Ser, 2000. 894: P. i-xii, 1-253
29. Hanon O et al (2000) Are the 1999 World Health Organization-International Society of Hypertension recommendations applicable to clinical practice? Arch Mal Coeur Vaiss 93(8):953-957
30. Sampaio MF et al (2007) AMI is associated with polymorphisms in the NOS3 and FGB but not in PAI-1 genes in young adults. Clin Chim Acta 377(1-2):154-162
31. Salazar LA et al (1998) Optimized procedure for DNA isolation from fresh and cryopreserved clotted human blood useful in clinical molecular testing. Clin Chem 44(8 Pt 1):1748-1750
32. Lima-Neto LG et al (2009) Detection of the TLR4 1196C>T polymorphism by mismatched-polymerase chain reaction using plasmid DNA as internal control in restriction fragment length polymorphism assays. Genet Test Mol Biomarkers 13(3):343-347
33. Chapman CM et al (2003) Association of an allelic variant of interleukin-6 with subclinical carotid atherosclerosis in an Australian community population. Eur Heart J 24(16):1494-1499
34. Ortlepp JR et al (2005) Additive effects of the chemokine receptor 2, vitamin D receptor, interleukin-6 polymorphisms and cardiovascular risk factors on the prevalence of myocardial infarction in patients below 65 years. Int J Cardiol 105(1):90-95
35. Panoulas VF et al (2009) Association of interleukin-6 (IL-6)-174G/C gene polymorphism with cardiovascular disease in patients with rheumatoid arthritis: The role of obesity and smoking. Atherosclerosis 204(1):178-183
36. Arroyo-Espliguero R et al (2005) CD14 C(-260)T promoter polymorphism and prevalence of acute coronary syndromes. Int J Cardiol 98(2):307-312
37. Bernardo E et al (2006) Influence of the CD14 C260T promoter polymorphism on C-reactive protein levels in patients with coronary artery disease. Am J Cardiol 98(9):1182-1184
38. Porsch-Ozcurumez M et al (2007) Post hoc analysis on the CD14 C(-260)T promoter polymorphism and coronary heart disease. Physiol Res 56(6):727-733
39. Garcia-Bermudez M et al (2012) Lack of association between TLR4 rs4986790 polymorphism and risk of cardiovascular disease in patients with rheumatoid arthritis. DNA Cell Biol 31(7):1214-1220
40. Koch W et al (2006) Toll-like receptor 4 gene polymorphisms and myocardial infarction: no association in a Caucasian population. Eur Heart J 27(21):2524-2529
41. Riikola A et al (2009) Interleukin-6 promoter polymorphism and cardiovascular risk factors: The Health 2000 Survey. Atherosclerosis 207(2):466-470
42. Shen J et al (2008) The effect of IL6-174C/G polymorphism on postprandial triglyceride metabolism in the GOLDN studyboxs. J Lipid Res 49(8):1839-1845
43. Ljungman P et al (2009) DNA variants, plasma levels and variability of interleukin-6 in myocardial infarction survivors: Results from the AIRGENE study. Thromb Res 124(1):57-64
44. Watt MJ et al (2005) Hormone-sensitive lipase is reduced in the adipose tissue of patients with type 2 diabetes mellitus: Influence of IL-6 infusion. Diabetologia 48(1):105-112
45. Miranville A et al (2010) Reversal of inflammation-induced impairment of glucose uptake in adipocytes by direct effect of CB1 antagonism on adipose tissue macrophages. Obesity (Silver Spring) 18(12):2247-2254
46. Amar J et al (2004) CD14 C(-260)T gene polymorphism, circulating soluble CD14 levels and arteriosclerosis. J Hypertens 22(8):1523-1528
47. Giacconi R et al (2007) CD14 C (-260)T polymorphism, atherosclerosis, elderly: Role of cytokines and metallothioneins. Int J Cardiol 120(1):45-51
48. Krimbou L, Marcil M, Genest J (2006) New insights into the biogenesis of human high-density lipoproteins. Curr Opin Lipidol 17(3):258-267
49. Tall AR (2008) Cholesterol efflux pathways and other potential mechanisms involved in the athero-protective effect of high density lipoproteins. J Intern Med 263(3):256-273
50. Morange PE et al (2004) TLR4/Asp299Gly, CD14/C-260T, plasma levels of the soluble receptor CD14 and the risk of coronary heart disease: The PRIME Study. Eur J Hum Genet 12(12):1041-1049
51. Stoica AL et al (2010) Interleukin-6 and interleukin-10 gene polymorphism, endothelial dysfunction, and postoperative prognosis in patients with peripheral arterial disease. J Vasc Surg 52(1):103-109
52. Labrum R et al (2007) Toll receptor polymorphisms and carotid artery intima-media thickness. Stroke 38(4):1179-1184
53. Tonet AC et al (2008) Association between the -174 G/C promoter polymorphism of the interleukin-6 gene and cardiovascular disease risk factors in Brazilian older women. Braz J Med Biol Res 41(1):47-53
54. Banerjee I et al (2009) Association between inflammatory gene polymorphisms and coronary artery disease in an Indian population. J Thromb Thrombolysis 27(1):88-94